GEOVAX LABS, INC.
Income Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Revenue | $1.1M | $828.9K |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $2.0M | $2.0M |
| SG&A Expense | $1.2M | $2.1M |
| Operating Income | $-2.2M | $-3.3M |
| Operating Margin | -202.2% | -394.9% |
| Interest Expense | — | — |
| Pretax Income | — | — |
| Income Tax Expense | $0 | $0 |
| Net Income | $-2.2M | $-3.3M |
| Net Margin | -201.8% | -394.7% |
| EPS (Basic) | $-0.01 | $-0.02 |
| EPS (Diluted) | $-0.01 | $-0.02 |
| Shares Outstanding (Basic) | 533.7M | 276.2M |
| Shares Outstanding (Diluted) | 533.7M | 276.2M |
| Dividends Per Share | — | — |